{"id":800336,"date":"2025-01-14T05:50:28","date_gmt":"2025-01-14T10:50:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/"},"modified":"2025-01-14T05:50:28","modified_gmt":"2025-01-14T10:50:28","slug":"february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/","title":{"rendered":"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n NEW YORK<\/span>
\n <\/span>, Jan. 14, 2025<\/span><\/span> \/PRNewswire\/ — Levi &\u00a0Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc.<\/b> (“Kyverna Therapeutics, Inc.” or the “Company”) (NASDAQ: KYTX) of a class action securities lawsuit.<\/p>\n

\n

\n
\n \"Levi
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n CLASS DEFINITION: <\/b>The lawsuit seeks to recover losses on behalf of Kyverna Therapeutics, Inc. investors who were adversely affected by alleged<\/span> securities fraud<\/span>. This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and\/or traceable to the Company’s offering documents issued in connection with its February 2024<\/span> initial public offering. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n

\n https:\/\/zlk.com\/pslra-1\/kyverna-therapeutics-inc-lawsuit-submission-form?prid=122508&wire=4<\/a>\n <\/p>\n

\n KYTX<\/b>\u00a0investors may also contact Joseph E. Levi, Esq.<\/span> via email at\u00a0jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n

\n CASE DETAILS: <\/b>The filed complaint alleges<\/span> that defendants made false statements and\/or concealed that: (i) the strategy to best accomplish the IPO; (ii) the terms of the IPO, including the price at which Kyverna’s common stock would be sold; (iii) the language to be used in the Offering Documents; (iv) what disclosures about Kyverna would be made in the Offering Documents; and (v) what responses would be made to the SEC in connection with its review of the Offering Documents. As a result of those constant contacts and communications between the underwriter defendants’ representatives and Kyverna’s management, directors, and lawyers, at a minimum, the underwriterd defendants should have known of Kyverna’s undisclosed then-existing problems and plans, and the Offering Document’s materially inaccurate, misleading, and incomplete statements and omissions, as detailed herein.<\/p>\n

\n WHAT’S NEXT? <\/b>If you suffered a loss in Kyverna Therapeutics, Inc. during the relevant time frame, you have until February 7, 2025<\/span><\/b>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.<\/p>\n

\n NO COST TO YOU: <\/b>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.<\/b><\/p>\n

\n WHY LEVI & KORSINSKY: <\/b>Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States<\/span>.<\/p>\n

\n CONTACT:<\/b>
\n
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.<\/span>
Ed Korsinsky, Esq.<\/span>
33 Whitehall Street, 17th Floor
New York, NY<\/span> 10004
jlevi@levikorsinsky.com<\/a>
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com<\/a><\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/february-7-2025-deadline-contact-levi–korsinsky-to-join-class-action-suit-against-kytx-302349624.html<\/a><\/p>\n

SOURCE Levi & Korsinsky, LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK , Jan. 14, 2025 \/PRNewswire\/ — Levi &\u00a0Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. (“Kyverna Therapeutics, Inc.” or the “Company”) (NASDAQ: KYTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyverna Therapeutics, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and\/or traceable to the Company’s offering documents issued in connection with its February 2024 initial public offering. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/kyverna-therapeutics-inc-lawsuit-submission-form?prid=122508&wire=4 KYTX\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by … <\/p>\n

Continue reading “February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-800336","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFebruary 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Jan. 14, 2025 \/PRNewswire\/ — Levi &\u00a0Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. (“Kyverna Therapeutics, Inc.” or the “Company”) (NASDAQ: KYTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyverna Therapeutics, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and\/or traceable to the Company’s offering documents issued in connection with its February 2024 initial public offering. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/kyverna-therapeutics-inc-lawsuit-submission-form?prid=122508&wire=4 KYTX\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by … Continue reading "February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-14T10:50:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX\",\"datePublished\":\"2025-01-14T10:50:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/\"},\"wordCount\":490,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/\",\"name\":\"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"datePublished\":\"2025-01-14T10:50:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/","og_locale":"en_US","og_type":"article","og_title":"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX - Market Newsdesk","og_description":"PR Newswire NEW YORK , Jan. 14, 2025 \/PRNewswire\/ — Levi &\u00a0Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. (“Kyverna Therapeutics, Inc.” or the “Company”) (NASDAQ: KYTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyverna Therapeutics, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and\/or traceable to the Company’s offering documents issued in connection with its February 2024 initial public offering. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/kyverna-therapeutics-inc-lawsuit-submission-form?prid=122508&wire=4 KYTX\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by … Continue reading \"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-14T10:50:28+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX","datePublished":"2025-01-14T10:50:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/"},"wordCount":490,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/","name":"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","datePublished":"2025-01-14T10:50:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/february-7-2025-deadline-contact-levi-korsinsky-to-join-class-action-suit-against-kytx\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/800336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=800336"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/800336\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=800336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=800336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=800336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}